Mouse Monoclonal Anti-Human beta-site APP cleaving enzyme protein (BACE/Asp2) IgG #3, aff. Pure
General Information
-amyloid (A ) deposition in the brain is the hallmark of Alzheimer's Disease (AD). To initiate A formation, -secretase cleaves APP at the N-terminus of A to release APPs (~100 kDa soluble NT-fragment), and C99, a 12-kDa CT membrane fragment. Altern
SugApplications
Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the
SugSecAntibodies
http://4adi.com/comm
SpeciesReactivity
Human
SugNegativeControl
Non-immune Rabbit IgG Cat# 20008-1
Form
Antibody Pure IgG
SugPositiveControl
Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid
Antigen
Recombinant human Bace protein EC domain
SpCrossreactivity
The antibody is specific for human bace. Antibody crossreactivity in various species is not established.
For research use only, not for diagnostic or therapeutic use.
| Alpha Diagnostic International, Inc. | |
|---|---|
| Product Category | Biological Materials |
| Product Number | BACE13-M |
| Product Name | Mouse Monoclonal Anti-Human beta-site APP cleaving enzyme protein (BACE/Asp2) IgG #3, aff. Pure |